February 23, 2006
Equitable Access License in Alligator column
Excellent column in today’s Alligator, “Research licenses could aid the poor“:
Here’s where the EAL comes in. Essentially, it’s a template contract between universities and pharmaceutical companies, but it allows the patent to be licensed to other generic drug producers in poorer countries. When there isn’t a single producer licensed to monopolize a medicine, other generic producers can compete, and prices naturally go down. …
Publicly funded universities, including UF, should be guided by ethical patent licensing and adopt methods, such as the EAL, that allow the poorest among us to benefit from their research.
Also to note: Our friends Universities Allied for Essential Medicines, who are organizing for the EAL, are finally officially registered and have their own Web site.
For more background on the EAL, see the UAEM national Web site.
Comments(2)



